avelumab 200 MG in 10 ML Injection
- RxCUI
- 1875542
- RxNorm name
- avelumab 200 MG in 10 ML Injection
- Display name
- avelumab 200 MG in 10 ML Injection
- Full name
- avelumab 200 MG in 10 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761049 | Bavencio | avelumab | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BAVENCIO | AVELUMAB | EMD Serono, Inc. | 5cd725a1-2fa4-408a-a651-57a7b84b2118 | 2025-06-13 | Warnings, Adverse reactions | 1875542 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5cd725a1-2fa4-408a-a651-57a7b84b2118 | avelumab 200 MG in 10 ML Injection | PSN | 23 | These highlights do not include all the information needed to use BAVENCIO safely and effectively. See full prescribing information for BAVENCIO. BAVENCIO ® (avelumab) injection, for intravenous use Initial U.S. Approval: 2017 | 20250613 |
| 5cd725a1-2fa4-408a-a651-57a7b84b2118 | 10 ML avelumab 20 MG/ML Injection | SCD | 23 | These highlights do not include all the information needed to use BAVENCIO safely and effectively. See full prescribing information for BAVENCIO. BAVENCIO ® (avelumab) injection, for intravenous use Initial U.S. Approval: 2017 | 20250613 |